Skip to content
Nexus Surgical and Medicare logo

Nexus Surgical and Medicare

538874 BSE
Price unavailable

Nexus Surgical and Medicare (NEXUSSURGL) share price was ₹21.48 at the 28 Oct 2026 close; market capitalisation ₹11.77 Cr; P/E (TTM) 15.02; sector Financial Services. The share price rose 14.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 47.4% year on year to ₹2.55 Cr and net profit was ₹0.20 Cr, against ₹0.15 Cr a year earlier (compared with Jun 2025). Promoters held 18.73% of Nexus Surgical and Medicare in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 66/100 (Strong) as of 28 Oct 2026.

Close 28 Oct 2026 ₹21.48 +4.18 +24.16% 1Y

Key Fundamentals

MicrocapFinanceFinancial Services
Market Cap
₹11.77 Cr
P/E (TTM)
15.02
EBITDA
₹1.00 Cr
Return on Equity
40.9%
Debt to Equity
0
Book Value
₹3.29
EPS (TTM)
₹1.43
52W High
₹35.79
52W Low
₹13.26

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Financial Services › Other Financial Services

CRISIL
₹4,691.9038.8034,312 Cr10.490.77%25.25%31.04%4,420 Cr884 Cr
RRP Semiconductor
——10,960 Cr1,266.830.00%-85.77%-48.08%-7 Cr-8 Cr
OnEMI Technology Solutions
₹317.508.755,628 Cr2.150.00%20.96%32.93%2,420 Cr317 Cr
Colab Platforms
—515.002,521 Cr—0.02%0.00%0.00%174 Cr5 Cr
Algoquant Fintech
₹75.9147.742,134 Cr15.880.00%24.84%28.77%259 Cr45 Cr
Nexus Surgical and Medicare (this company)
—15.0212 Cr6.530.00%40.90%54.87%9 Cr1 Cr
Asset Reconstruction Company (India)
₹129.20————————
GYFTR
₹158.99————————
Median 8 companies₹158.9938.804,075 Cr10.490.00%22.90%29.91%217 Cr25 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

66 Strong
Overall score

Data confidence 94/100

Category scores

Quality Strong 94
Returns, margins, earnings quality 22% weight
Valuation Average 46
Cheap vs sector & own history 24% weight
Growth Strong 75
Sales & profit trajectory 9% weight
Financial Health Strong 73
Solvency, leverage, coverage 9% weight
Momentum Strong 66
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 53.8%

Weaknesses

2
  • Stock is trading at 10.1 times its book value
  • Promoter holding is low: 18.7%

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
1
Bullish
6

Overall

Bearish

Bearish
11
Neutral
1
Bullish
7

Moving Averages

Bearish

Bearish
9
Neutral
0
Bullish
1

Growth Rate

Revenue Growth
38.6% lower than 3Y

change over 1 year

Net Income Growth
40% lower than 3Y

change over 1 year

Cash Flow Change
70%

change over 1 year

EBITDA Margin Change
7.08%

change over 1 year Operating margin 9.41% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
1.06
0.37
1.45
0.6
1.76
0.99
1.48
1.48
1.73
1.17
2.93
2.05
2.55
Expenses
1.03
0.28
1.4
0.52
1.64
0.71
1.33
1.37
1.53
0.94
2.71
1.75
2.31
Operating Profit
0.03
0.09
0.05
0.08
0.12
0.28
0.15
0.11
0.2
0.23
0.22
0.3
0.24
OPM %
2.83%
24.32%
3.45%
13.33%
6.82%
28.28%
10.14%
7.43%
11.56%
19.66%
7.51%
14.63%
9.41%
Other Income
0.01
0.02
0.01
0
0
0
0
0.01
0
0
0.01
0.02
0.03
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0.04
0.11
0.06
0.08
0.12
0.28
0.15
0.12
0.2
0.23
0.23
0.32
0.27
Tax %
25%
27.27%
33.33%
25%
25%
25%
26.67%
25%
25%
26.09%
26.09%
25%
25.93%
Net Profit
0.03
0.08
0.05
0.06
0.09
0.21
0.11
0.09
0.15
0.17
0.17
0.24
0.2
EPS (₹)
0.05
0.15
0.09
0.11
0.16
0.38
0.2
0.16
0.27
0.31
0.31
0.44
0.37
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0.43
0.33
0.3
0.98
2.14
1.73
3.74
2.4
1.55
3.47
5.72
7.87
8.7
Expenses
0.21
0.25
0.48
1.36
2.32
1.66
3.58
2.03
1.33
3.2
5.05
6.9
7.71
Operating Profit
0.22
0.08
-0.18
-0.38
-0.18
0.07
0.16
0.37
0.22
0.27
0.67
0.97
0.99
OPM %
51.16%
24.24%
-60%
-38.78%
-8.41%
4.05%
4.28%
15.42%
14.19%
7.78%
11.71%
12.33%
11.38%
Other Income
0
0
0
0.06
0.08
-5.35
0.01
0.02
0.01
0.03
0.01
0.03
0.06
Interest
0
0.01
0.01
0
0
0
0
0
0
0.01
0.01
0.01
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0.22
0.07
-0.19
-0.32
-0.1
-5.28
0.17
0.39
0.23
0.29
0.67
0.99
1.05
Tax %
31.82%
28.57%
0%
3.12%
0%
0.38%
5.88%
25.64%
26.09%
27.59%
25.37%
25.25%
—
Net Profit
0.15
0.05
-0.19
-0.33
-0.11
-5.3
0.15
0.29
0.17
0.21
0.5
0.74
0.78
EPS (₹)
0.27
0.09
-0.35
-0.6
-0.2
-9.69
0.27
0.53
0.31
0.38
0.91
1.35
1.43
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5.47
5.47
5.47
5.47
5.47
5.47
5.47
5.47
5.47
5.47
5.47
5.47
Reserves
0.12
0.17
0
-0.33
-0.44
-5.73
-5.58
-5.29
-5.12
-4.91
-4.41
-3.67
Borrowings
0
0.09
0.29
0.25
0.26
0
0
0
0
0
0
0
Other Liabilities
0.13
0.04
0.18
0.2
0.2
0.47
1.04
1.82
0.56
1.25
1.21
1.85
Total Liabilities
5.72
5.77
5.94
5.59
5.49
0.21
0.93
2
0.91
1.81
2.27
3.65
Fixed Assets
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.02
0.02
CWIP
5.35
5.35
5.35
5.35
5.35
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0.34
0.39
0.56
0.22
0.12
0.19
0.91
1.99
0.89
1.79
2.25
3.63
Total Assets
5.72
5.77
5.94
5.59
5.49
0.21
0.93
2
0.91
1.81
2.27
3.65
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.03
-0.03
-0.17
-0.07
0.02
0.24
0.2
-0.11
0.55
-0.41
0.1
0.17
Investing
0
0
0
0
0
0
0
0
-0.01
0
-0.01
0
Financing
0
0.09
0.2
-0.04
0.01
-0.26
0
0
0
0
0
0
Net Cash Flow
0.03
0.05
0.03
-0.11
0.03
-0.02
0.2
-0.11
0.54
-0.42
0.1
0.17
Free Cash Flow
0.03
-0.03
-0.17
-0.07
0.02
0.24
0.2
-0.11
0.54
-0.41
0.09
0.17
CFO/OP
23
12
94
18
-11
343
125
-30
250
-152
15
18
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
153
254
292
37.24
6.82
0
11.71
0
9.42
78.89
85.51
61.22
Inventory Days
—
156
138
15.21
0
0
0
—
56.78
243
83.93
55.35
Days Payable
—
104
227
72.24
—
—
—
—
454
754
230
239
Cash Conversion Cycle
153
307
204
-19.79
6.82
0
11.71
0
-388
-432
-60.88
-123
Working Capital Days
153
277
-73
-101
-66.52
-73.84
-43.92
-19.77
-77.71
29.45
44.67
58.9
ROCE %
3.96%
1.41%
-3.13%
-5.74%
-1.87%
2.78%
—
1114.29%
86.79%
65.93%
83.95%
69.93%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Nexus Surgical and Medicare insights

54 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

Public42.38%Promot.18.73%Others38.89%As ofSep 2026

Documents

Frequently Asked Questions about Nexus Surgical and Medicare

What does Nexus Surgical and Medicare Ltd do?
Incorporated in 1992, Nexus Surgical and Medicare Ltd deals in medical disposable, surgical equipment, pharmaceutical products[1]
Where is Nexus Surgical and Medicare Ltd (NEXUSSURGL) listed?
Nexus Surgical and Medicare Ltd trades under code 538874 on the BSE.
Which sector does Nexus Surgical and Medicare Ltd belong to?
Nexus Surgical and Medicare Ltd is classified under the Financial Services sector, in the Other Financial Services industry.
What is the market capitalisation of Nexus Surgical and Medicare Ltd?
Nexus Surgical and Medicare Ltd has a market capitalisation of ₹11.77 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Nexus Surgical and Medicare Ltd?
Nexus Surgical and Medicare Ltd trades at a PE ratio of 15.02 as of 28 Oct 2026, on earnings per share of ₹1.43, against a book value of ₹3.29 per share.
What is the 52-week high and low of Nexus Surgical and Medicare Ltd?
Over the last 52 weeks Nexus Surgical and Medicare Ltd has traded between ₹13.26 and ₹35.79 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Nexus Surgical and Medicare Ltd?
Nexus Surgical and Medicare Ltd reported a return on equity of 40.90%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1992, Nexus Surgical and Medicare Ltd deals in medical disposable, surgical equipment, pharmaceutical products[1]

Website nexusmed.co.in
Face Value ₹ 10
Shares Outstanding 54,79,452

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/538874.md for Nexus Surgical and Medicare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More NBFC & Finance stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month